HUMAW
Humacyte, Inc.
Overview
Humacyte, Inc.
Most recent reported earnings: Q2 FY2021 (Sep 29, 2021).
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
History
Earnings history
- Q2 FY20212021-09-29EPS$-0.72 vs $0.00—Rev$690.0K vs ——EODHD
- Q1 FY20212021-06-29EPS$-0.76 vs $0.00—Rev$155.0K vs ——EODHD
- Q4 FY20202021-03-30EPS$-0.91 vs $0.00—Rev$124.0K vs ——EODHD
- Q2 FY20202020-09-29EPS$-3.07 vs $0.00—Rev$198.0K vs ——EODHD
- Q1 FY20202020-06-29EPS$-0.68 vs $0.00—Rev$255.0K vs ——EODHD
- Q4 FY20192020-03-30EPS$-0.81 vs $0.00—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2021 | 2021-09-29 | $-0.72 | $0.00 | — | $690.0K | — | — | EODHD |
| Q1 FY2021 | 2021-06-29 | $-0.76 | $0.00 | — | $155.0K | — | — | EODHD |
| Q4 FY2020 | 2021-03-30 | $-0.91 | $0.00 | — | $124.0K | — | — | EODHD |
| Q2 FY2020 | 2020-09-29 | $-3.07 | $0.00 | — | $198.0K | — | — | EODHD |
| Q1 FY2020 | 2020-06-29 | $-0.68 | $0.00 | — | $255.0K | — | — | EODHD |
| Q4 FY2019 | 2020-03-30 | $-0.81 | $0.00 | — | — | — | — | EODHD |
Source: EODHD. HUMAW reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks HUMAW's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 90% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.71 | $1.43 | +19.5% | -6.4% | -9.0% |
| Q4 FY2026 | $1.82 | $1.55 | +17.1% | +1.9% | -0.2% |
| Q3 FY2026 | $1.91 | $1.50 | +27.6% | -9.5% | -10.8% |
| Q2 FY2026 | $1.61 | $1.42 | +13.4% | -2.6% | -0.4% |
| Q1 FY2025 | $1.84 | $1.46 | +26.3% | -8.5% | -9.3% |
| Q4 FY2025 | $1.75 | $1.39 | +25.8% | -4.7% | -3.7% |
| Q3 FY2025 | $1.89 | $1.51 | +25.0% | -1.5% | -0.1% |
| Q2 FY2025 | $1.85 | $1.46 | +27.0% | -2.0% | -1.8% |
| Q1 FY2024 | $2.00 | $1.58 | +26.8% | -2.5% | -2.4% |
| Q4 FY2024 | $1.78 | $1.47 | +20.8% | -2.0% | -4.2% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Laura E NiklasonCEO1 yr 7 mo15 callsCurrentSample
CEO since 2024 • 6/8 beats (75%) • last call held guidance Q3 FY2026
- Dale A SanderCFO1 yr 6 mo17 callsCurrentSample
CFO since 2024 • 6/8 beats (75%) • last call held guidance Q1 FY2026
- Shamik J ParikhChief Medical Officer1 yr 5 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance raise Q1 FY2026
- Heather Ledbetter PrichardCOO1 mono recorded callsFormerSample
COO since 2024 • 6/8 beats (75%) • last guidance raise Q1 FY2026
- William John ScheesseleChief Commercial Officer3 mo1 callFormerSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • guidance suspended Q2 FY2026
- Yang CaoChief Regulatory Officer0 mono recorded callsFormerSample
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance cut Q2 FY2026
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for HUMAW.
$ curl https://api.spokenalpha.com/v1/companies/HUMAWFAQ
Frequently asked about HUMAW
Where can I find Humacyte, Inc.'s (HUMAW) earnings call transcripts?
Spoken Alpha indexes HUMAW's earnings call transcripts at https://spokenalpha.com/companies/HUMAW. Each call links to attributed speakers and parsed analyst Q&A.